Screening and Surveillance
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Pancreatic cancer is most often caught late — but that is starting to change. In this episode of PancChat, host Alisyn Camerota sits down with Dr. Raymond Wadlow, a gastrointestinal oncologist at the Inova Schar Cancer Institute and director of the High Risk Pancreatic Clinic, to talk about what screening and surveillance actually mean for people at elevated risk of developing pancreatic cancer.
Dr. Wadlow walks through who qualifies for screening, which genetic mutations and family history patterns matter, and what the current imaging protocols look like. He also explains the promise and limitations of blood-based tests in development, the challenges of interval cancers, and how the PRECEDE consortium — now spanning 64 sites worldwide — is working to prove that finding this disease earlier saves lives.
PancChat is a collaboration between Let's Win Pancreatic Cancer and PanCAN. Find us wherever you listen to podcasts.